Brief: Mustang Bio-On May 24, Received Letter From Staff Of Nasdaq, Co Not In Compliance With Minimum Bid Price Requirement Of Nasdaq Listing Rule
31/05/2022 14:12
May 31 (Reuters) - Mustang Bio Inc MBIO.O :
* MUSTANG BIO-ON MAY 24, RECEIVED LETTER FROM STAFF OF
NASDAQ, CO
NOT IN COMPLIANCE WITH MINIMUM BID PRICE REQUIREMENT OF NASDAQ
LISTING RULE
* MUSTANG BIO- CO TO CONSIDER ALL AVAILABLE OPTIONS TO
REMEDY BID
PRICE DEFICIENCY, BUT NO DECISION REGARDING ANY ACTION HAS YET
BEEN MADE
Source: [https://bit.ly/3N5JMBF]
Further company coverage: MBIO.O
Recent news on Mustang Bio
See all newsAdvisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
U.S. STOCKS ON THE MOVE-Dow, Phibro, Mustang Bio
Mustang soars on FDA's orphan drug tag for brain cancer therapy
Mustang Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Mustang Bio Inc - Enters Sale And Surrender Agreement With Abbvie